CH379511A - Verfahren zur Herstellung neuer Alkylxanthinderivate - Google Patents

Verfahren zur Herstellung neuer Alkylxanthinderivate

Info

Publication number
CH379511A
CH379511A CH7831359A CH7831359A CH379511A CH 379511 A CH379511 A CH 379511A CH 7831359 A CH7831359 A CH 7831359A CH 7831359 A CH7831359 A CH 7831359A CH 379511 A CH379511 A CH 379511A
Authority
CH
Switzerland
Prior art keywords
alkylxanthine
derivatives
preparation
new
new alkylxanthine
Prior art date
Application number
CH7831359A
Other languages
English (en)
Inventor
Klingler Karl-Heinz Dipl-Chem
Erwin Dr Kohlstaedt
Original Assignee
Chemiewerk Homburg Zweignieder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemiewerk Homburg Zweignieder filed Critical Chemiewerk Homburg Zweignieder
Publication of CH379511A publication Critical patent/CH379511A/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH7831359A 1958-10-18 1959-09-17 Verfahren zur Herstellung neuer Alkylxanthinderivate CH379511A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1958C0017685 DE1123329B (de) 1958-10-18 1958-10-18 Verfahren zur Herstellung von basisch substituierten Alkylxanthinderivaten.

Publications (1)

Publication Number Publication Date
CH379511A true CH379511A (de) 1964-07-15

Family

ID=7016288

Family Applications (1)

Application Number Title Priority Date Filing Date
CH7831359A CH379511A (de) 1958-10-18 1959-09-17 Verfahren zur Herstellung neuer Alkylxanthinderivate

Country Status (4)

Country Link
CH (1) CH379511A (de)
DE (1) DE1123329B (de)
FR (1) FR479M (de)
GB (1) GB927288A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3245994A (en) * 1966-04-12 Theophylline derivatives
DE1221641B (de) * 1962-03-30 1966-07-28 Degussa Verfahren zur Herstellung von basisch substituierten Theophyllinderivaten
DE1237578B (de) * 1963-05-10 1967-03-30 Knoll Ag Verfahren zur Herstellung basisch substituierter Xanthinderivate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1011424B (de) * 1954-04-17 1957-07-04 Chemiewerk Homburg Ag Verfahren zur Herstellung von basisch substituierten 7-Alkyl-xanthinderivaten oder deren Salzen

Also Published As

Publication number Publication date
DE1123329B (de) 1962-02-08
FR479M (de) 1961-05-02
GB927288A (en) 1963-05-29

Similar Documents

Publication Publication Date Title
CH367509A (de) Verfahren zur Herstellung neuer Thiophenderivate
AT258875B (de) Verfahren zur Herstellung neuer β-Aminopropionsäureamidderivate
AT244965B (de) Verfahren zur Herstellung neuer heterocyclischer Benzocycloheptan-Derivate
CH374684A (de) Verfahren zur Herstellung neuer Theophyllinbasen
CH370504A (de) Verfahren zur Herstellung neuer Monoazofarbstoffe
CH377839A (de) Verfahren zur Herstellung von a-Phenylbenzoyl-a-arylaminocarbinolderivaten
CH379511A (de) Verfahren zur Herstellung neuer Alkylxanthinderivate
CH383379A (de) Verfahren zur Herstellung neuer basischer Indol-Derivate
CH379494A (de) Verfahren zur Herstellung neuer Halogenpregnene
CH402226A (de) Verfahren zur Herstellung neuer Azophthalocyaninfarbstoffe
CH364790A (de) Verfahren zur Herstellung neuer 1,3,4-Oxdiazole
CH407119A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH373392A (de) Verfahren zur Herstellung neuer Azaverbindungen
CH383960A (de) Verfahren zur Herstellung von gonadenhemmenden Derivaten des 17-epi-Oestriols
CH410950A (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH390915A (de) Verfahren zur Herstellung neuer Bicyclo (2,2,2)octanderivate
AT210412B (de) Verfahren zur Herstellung neuer 5-Nitrofuran-Derivate
CH376501A (de) Verfahren zur Herstellung neuer Pregnan-18-säure-Derivate
CH376104A (de) Verfahren zur Herstellung neuer Pregnan-18-säure-Derivate
CH386438A (de) Verfahren zur Herstellung neuer 7-Aza-benzimidazole
CH356464A (de) Verfahren zur Herstellung neuer Tetrahydrodioxopyridazine
CH376106A (de) Verfahren zur Herstellung neuer ungesättigter 6-Halogen-pregnanverbindungen
CH367824A (de) Verfahren zur Herstellung neuer Halogenandrostene
CH383372A (de) Verfahren zur Herstellung neuer 2-Fluorsteroide
AT210432B (de) Verfahren zur Herstellung neuer p-Diaminobenzolderivate